201
|
Park K, Tan E, O’Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Yang J, Schuler M, Yamamoto N, Sequist L, Wu Y, Zhou C, Ehrnrooth E, Märten A, Tang W, Paz-Ares L. P3.01-039 Sequential Afatinib-Osimertinib Therapy in EGFR Mutation-Positive (EGFRm+) NSCLC: Analysis of Time on Treatment and OS. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1480] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
202
|
Satouchi M, Fehrenbacher L, Dols MC, Han J, Von Pawel J, Bordoni R, Hida T, Park K, Moro-Sibilot D, Conkling P, Matheny C, Yu W, He P, Kowanetz M, Gandhi M, Ballinger M, Sandler A, Gandara D. OA 17.07 Long-Term Survival in Atezolizumab-Treated Patients with 2L+ NSCLC from Ph III Randomized OAK Study. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.432] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
203
|
Nakagawa K, Garon E, Paz-Ares L, Ponce S, Jaime JC, Vidal OJ, Nadal E, Kiura K, Park K, Widau R, Alexandris E, He S, Lee P, Reck M. P3.01-071 Randomized Phase 1b/3 Study of Erlotinib + Ramucirumab in Untreated EGFR Mutation-Positive Stage IV NSCLC: Phase 1b Outcomes. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
204
|
Cho B, Kim D, Park K, Lee J, Yoo S, Kang J, Lee S, Kim C, Jang S, Kim Y, Yoon H, Kim S. P3.01-050 A Real World Treatment Study of Osimertinib: ASTRIS Study Korean Subgroup Analysis. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
205
|
Reck M, Shepherd F, Pérol M, Cappuzzo F, Shih J, Park K, Winfree K, Alexandris E, Lee P, Sashegyi A, Garon E. MA 03.06 Effect of 2L Ramucirumab after Rapid Time to Progression on 1L Therapy: Subgroup Analysis of REVEL in Advanced NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.464] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
206
|
Schuler M, Yang J, Sequist L, Wu Y, Zhou C, Geater S, Mok T, Tan E, Hu C, Yamamoto N, Feng J, O’Byrne K, Lu S, Hirsh V, Huang Y, Ellis S, Samuelsen C, Märten A, Fan J, Park K, Paz-Ares L. P3.01-026 Analysis of Long-Term Response to First-Line Afatinib in the LUX-Lung 3, 6 and 7 Trials in Advanced EGFRm+ NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
207
|
Kim H, Shin S, Cho J, Choi Y, Zo J, Shim Y, Park K, Ahn M, Ahn J, Lee S, Sun J, Ahn Y, Pyo H, Noh J, Han J, Kim J. P3.08-006 Treatment Response and Survival Outcomes Are Associated with Histologic Type in Non-Small Cell Lung Cancer Treated with Trimodal Treatment. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
208
|
Sun J, Lee K, Kim B, Kim H, Min Y, Yi S, Yun H, Lee S, Ahn J, Park K, Ahn M. OA 08.07 Pazopanib Maintenance for Extensive Disease Small Cell Lung Cancer: a Randomized, Placebo-Controlled Phase II study (KCSG-LU12-07). J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
209
|
Sung W, Park J, Park K. PS06.04 Clinicopathologic Correlation of MACC1 and c-Met Expression in Lung Adenocarcinoma. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
210
|
Shin S, Cho J, Kim H, Choi Y, Kim J, Zo J, Park K, Ahn M, Ahn J, Sun J, Lee S, Shim Y. P3.01-082 Surgical Rebiopsy in Advanced Non-Small Cell Lung Cancer Resistant to Previous Chemotherapy. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
211
|
Sequist L, Wu Y, Schuler M, Kato T, Yang J, Tanaka H, Hida T, Lu S, Park K, Paz-Ares L, Laurie S, Bennouna J, Moro Sibilot D, Märten A, Tang W, Ehrnrooth E, Yamamoto N, Nakagawa K. PS02.20 Subsequent Therapies Post-Afatinib Among Patients with EGFR Mutation-Positive (EGFRm+) NSCLC in LUX-Lung 3, 6 and 7. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.058] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
212
|
Cho B, Obermannová R, Bearz A, Kim D, Orlov S, Borra G, Kim S, Postmus P, Laurie S, Park K, Geater S, Bettini A, Osborne K, Passos V, Chen Z, Dziadziuszko R. OA 05.07 Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.352] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
213
|
Kye SY, Shim M, Kim YC, Park K. Sharing health information online in South Korea: motives, topics, and antecedents. Health Promot Int 2017; 34:182-192. [DOI: 10.1093/heapro/dax074] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
214
|
Park K, Kim H, Oh B, Lee E, Ha J. 286 Assessment of hair surface roughness by objective analysis. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
215
|
Park K, Oeda T, Umemura A, Kohsaka M, Tomita S, Sugiyama H, Sawada H. Homeostasis in lipid metabolism is impaired in Parkinson's disease. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
216
|
Umemura A, Oeda T, Yamamoto K, Kohsaka M, Tomita S, Park K, Sugiyama H, Sawada H. Dementia in Parkinson’s disease is associated with the lateral cholinergic pathway. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
217
|
Ohara H, Park K, Kosaka M, Umemura A, Tomita S, Tahara M, Yamamoto K, Oeda T, Sugiyama H, Sawada H. Cerebral infarctions with hypereosinophilic syndrome: A report of two cases. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
218
|
Park W, Kim H, Lee S, Park K. 073_16192-H1 The Quality of Life After Ablative Therapy in Patients with Atrial Fibrillation In Korea. JACC Clin Electrophysiol 2017. [DOI: 10.1016/j.jacep.2017.09.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
219
|
Song H, Kim Y, Park J, Park M, Lyu S, Koh Y, Heo J, Lee D, Park K. Biocompatible nanoparticle PLGA is a noble safe delivery system for embryo development and next generations. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
220
|
Park K, Ciardiello F, Hida T, Lim W, Lin CC, Murakami H, Nishio M, Cantero F, Cattan V, Gabarroca C, Gandossi E, Paz-Ares L. Phase I/II study of S 49076, a MET/AXL/FGFR inhibitor, in combination with gefitinib in EGFR-mutated NSCLC patients who progress on EGFR tyrosine kinase inhibitor. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.080] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
221
|
Reck M, Yang CH, Postmus P, Barlesi F, Font E, Thomas M, Kim T, Cobo Dols M, Skuladottir H, Park K, Sullivan R, Veatch A, Pavlakis N, Dreosti L, Özgüroğlu M, Morgillo F, Schlichting M, Teofilovici F, Chand V, Westeel V. JAVELIN Lung 100: updated design of a phase 3 trial of avelumab vs platinum doublet chemotherapy as first-line (1L) treatment for metastatic or recurrent PD-L1+ non-small-cell lung cancer (NSCLC). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.078] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
222
|
Zhang X, Park K, Rizvi N, Dennis P, Narwal R, Huang Y, Arani R, Mukhopadhyay P. Prediction of survival with durvalumab in locally advanced or metastatic NSCLC using early tumor assessments. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
223
|
Gadgeel S, Kowanetz M, Zou W, Hirsch F, Kerr K, Gandara D, Barlesi F, Park K, McCleland M, Koeppen H, Ballinger M, Sandler A, Hegde P, Rittmeyer A. Clinical efficacy of atezolizumab (Atezo) in PD-L1 subgroups defined by SP142 and 22C3 IHC assays in 2L+ NSCLC: Results from the randomized OAK study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
224
|
Palmero R, Bidoli P, Bondarenko I, Boyer M, Germonpre P, Ghizdavescu D, Kotsakis A, Lena H, Losonczy G, Park K, Reck M, Su WC, Kallinteris N, Tang M, Lai J, Shan J, Spigel D. Final clinical results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/IV nonsquamous non-small cell lung cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.065] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
225
|
Lim S, Sun JM, Hong J, Oh D, Ahn Y, Chung M, Jeong HS, Son YI, Ahn MJ, Baek CH, Park K. Concurrent chemoradiotherapy (CCRT) versus induction docetaxel, cisplatin and 5-fluorouracil (TPF) followed by CCRT in locally advanced hypopharyngeal and base of tongue cancer: A randomized phase II study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx374.032] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
226
|
Sequist L, Wu YL, Schuler M, Kato T, Yang JH, Tanaka H, Hida T, Lu S, Park K, Laurie S, Bennouna J, Moro Sibilot D, Märten A, Peil B, Ehrnrooth E, Yamamoto N, Nakagawa K. Subsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC in LUX-Lung (LL) 3, 6 and 7. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.051] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
227
|
Sun JM, Ahn MJ, Ahn J, Kim H, Ahn Y, Zo J, Shim Y, Park K. Randomized phase ii trial comparing chemoradiotherapy with chemotherapy for completely resected unsuspected N2-positive non-small cell lung cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx379.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
228
|
Yang WC, Xie YT, Zhu WK, Park K, Chen AP, Losovyj Y, Li Z, Liu HM, Starr M, Acosta JA, Tao CG, Li N, Jia QX, Heremans JJ, Zhang SX. Epitaxial thin films of pyrochlore iridate Bi 2+xIr 2-yO 7-δ: structure, defects and transport properties. Sci Rep 2017; 7:7740. [PMID: 28798487 PMCID: PMC5552750 DOI: 10.1038/s41598-017-06785-w] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2016] [Accepted: 05/15/2017] [Indexed: 11/09/2022] Open
Abstract
While pyrochlore iridate thin films are theoretically predicted to possess a variety of emergent topological properties, experimental verification of these predictions can be obstructed by the challenge in thin film growth. Here we report on the pulsed laser deposition and characterization of thin films of a representative pyrochlore compound Bi2Ir2O7. The films were epitaxially grown on yttria-stabilized zirconia substrates and have lattice constants that are a few percent larger than that of the bulk single crystals. The film composition shows a strong dependence on the oxygen partial pressure. Density-functional-theory calculations indicate the existence of BiIr antisite defects, qualitatively consistent with the high Bi: Ir ratio found in the films. Both Ir and Bi have oxidation states that are lower than their nominal values, suggesting the existence of oxygen deficiency. The iridate thin films show a variety of intriguing transport characteristics, including multiple charge carriers, logarithmic dependence of resistance on temperature, antilocalization corrections to conductance due to spin-orbit interactions, and linear positive magnetoresistance.
Collapse
|
229
|
Lee D, Fontugne J, Gumpeni N, Park K, MacDonald TY, Robinson BD, Sboner A, Rubin MA, Mosquera JM, Barbieri CE. Molecular alterations in prostate cancer and association with MRI features. Prostate Cancer Prostatic Dis 2017; 20:430-435. [PMID: 28762374 DOI: 10.1038/pcan.2017.33] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2017] [Revised: 05/22/2017] [Accepted: 06/04/2017] [Indexed: 01/08/2023]
Abstract
BACKGROUND Multiparametric magnetic resonance imaging (mpMRI) has been increasingly used for prostate cancer (PCa). Recent studies identified distinct molecular subclasses of PCa with recurrent genomic alterations. However, the associations between molecular alterations in PCa and characteristics on mpMRI are unknown. Therefore, the objective of this study was to investigate recurrent molecular alterations in PCa and their associations with mpMRI features. METHODS Sixty-two PCa nodules >0.5 cm had a preoperative mpMRI. Nodules were evaluated for ERG rearrangement, PTEN deletion, SPINK1 overexpression, SPOP mutation and CHD1 deletion. Each PCa focus was matched to the corresponding location on mpMRI. Lesions were scored by single observer according to the PI-RADSv2 scale. RESULTS Of the 62 nodules, 22 (35.5%) were ERG positive, 6 (9.7%) had SPINK1 overexpression, 6 (9.7%) had SPOP mutations, 4 (6.5%) had CHD1 deletions and 1 (1.6%) had PTEN deletion. All of the nodules with CHD1 deletions were not visible on mpMRI (P=0.037). All of the nodules with SPINK1 overexpression were visible on mpMRI, although the association was not statistically significant (P=0.06). There were no significant associations between any molecular alteration with the severity of the PI-RADS scores (all P>0.05). CONCLUSIONS This investigation represents the first description of an association between recurrent molecular alterations and the characterization of PCa nodules on mpMRI. This study can be considered hypothesis-generating for future studies to rigorously evaluate the association of specific PCa molecular subclasses with imaging features and potentially define specific subsets of PCa for which the utility of MRI is higher or lower.
Collapse
|
230
|
Lesaffre E, Edelman M, Hanna N, Park K, Thatcher N, Willemsen S, Gaschler-Markefski B, Kaiser R, Manegold C. Statistical controversies in clinical research: futility analyses in oncology–lessons on potential pitfalls from a randomized controlled trial. Ann Oncol 2017; 28:1419-1426. [DOI: 10.1093/annonc/mdx042] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Indexed: 11/13/2022] Open
|
231
|
Kim Y, Lee H, Park B, Park K. PREDICTING HEALTH LITERACY AMONG DISABLED ELDERLY IN KOREA: IMPLICATIONS FOR HEALTH JUSTICE. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.1420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
232
|
Park Y, Son D, Park K, Park E, Choi Y. FACTORS AFFECTING EARLY DETECTION OF MENTAL HEALTH PROBLEMS OF THE ELDERLY AND SERVICE USE IN KOREA. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
233
|
Alam J, Koh JH, Kwok SK, Park SH, Park K, Choi Y. Functional Epitopes for Anti-Aquaporin 5 Antibodies in Sjögren Syndrome. J Dent Res 2017; 96:1414-1421. [PMID: 28665757 DOI: 10.1177/0022034517717965] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
We recently reported the presence of anti-aquaporin 5 (AQP5) immunoglobulin G (IgG) in patients with primary Sjögren syndrome (SS) with a sensitivity of 0.73 and a specificity of 0.68. The aim of this study was to identify functional epitopes for the anti-AQP5 autoantibodies detected in control subjects and patients with SS. Recognition of epitopes by anti-AQP5 autoantibodies in sera ( n = 13 for control and n = 24 for SS) or purified IgG ( n = 1 for control and n = 3 for SS) was evaluated by indirect immunofluorescence (IIF) assay performed in the presence or absence of peptides corresponding to the second transmembrane helix and extracellular loops A, C, and E of AQP5. Functional epitopes were determined by measuring the effects of purified IgG and neutralizing peptides on transepithelial osmotic permeability (PfT) of MDCK cells expressing AQP5. In the IIF assay, 89% of SS samples were inhibited by at least 1 peptide, while only half of control samples were inhibited by any peptide. Overall, SS samples were inhibited by peptides corresponding to extracellular loops A, C, and E by 40% to 50%, whereas control samples were inhibited only by peptides corresponding to loop E by <20%. A cyclized peptide (E1) mimicking loop E was most frequently recognized and best differentiated between the SS and control samples. Incubation of MDCK-AQP5 cells with SS but not with control IgG, significantly decreased PfT, which was reversed by neutralization of IgG binding to any of the extracellular loops. In conclusion, the anti-AQP5 autoantibodies detected in control and SS groups showed differences in fine specificity to the functional epitopes of AQP5. The prevalent recognition of functional epitopes by anti-AQP5 autoantibodies from SS patients suggests that anti-AQP5 autoantibodies act as mediators of glandular hypofunction and are a potential therapeutic target in SS.
Collapse
|
234
|
Ho D, Peng P, Bass C, Collins P, D'Angelo A, Deur A, Fleming J, Hanretty C, Kageya T, Khandaker M, Klein FJ, Klempt E, Laine V, Lowry MM, Lu H, Nepali C, Nikonov VA, O'Connell T, Sandorfi AM, Sarantsev AV, Schumacher RA, Strakovsky II, Švarc A, Walford NK, Wei X, Whisnant CS, Workman RL, Zonta I, Adhikari KP, Adikaram D, Akbar Z, Amaryan MJ, Anefalos Pereira S, Avakian H, Ball J, Bashkanov M, Battaglieri M, Batourine V, Bedlinskiy I, Biselli A, Briscoe WJ, Burkert VD, Carman DS, Celentano A, Charles G, Chetry T, Ciullo G, Clark L, Colaneri L, Cole PL, Contalbrigo M, Crede V, Dashyan N, De Sanctis E, De Vita R, Djalali C, Dupre R, El Alaoui A, El Fassi L, Elouadrhiri L, Eugenio P, Fedotov G, Fegan S, Fersch R, Filippi A, Fradi A, Ghandilyan Y, Gilfoyle GP, Girod FX, Glazier DI, Gleason C, Gohn W, Golovatch E, Gothe RW, Griffioen KA, Guidal M, Guo L, Hakobyan H, Harrison N, Hattawy M, Hicks K, Holtrop M, Hughes SM, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Jenkins D, Jiang H, Jo HS, Joo K, Joosten S, Keller D, Khachatryan G, Kim A, Kim W, Klein A, Kubarovsky V, Kuleshov SV, Lanza L, Lenisa P, Livingston K, MacGregor IJD, Markov N, McKinnon B, Mineeva T, Mokeev V, Montgomery RA, Movsisyan A, Munoz Camacho C, Murdoch G, Niccolai S, Niculescu G, Osipenko M, Paolone M, Paremuzyan R, Park K, Pasyuk E, Phelps W, Pogorelko O, Price JW, Procureur S, Protopopescu D, Ripani M, Riser D, Ritchie BG, Rizzo A, Rosner G, Sabatié F, Salgado C, Sharabian YG, Skorodumina I, Smith GD, Sober DI, Sokhan D, Sparveris N, Strauch S, Tian Y, Torayev B, Ungaro M, Voskanyan H, Voutier E, Watts DP, Wood MH, Zachariou N, Zhang J, Zhao ZW. Beam-Target Helicity Asymmetry for γ[over →]n[over →]→π^{-}p in the N^{*} Resonance Region. PHYSICAL REVIEW LETTERS 2017; 118:242002. [PMID: 28665642 DOI: 10.1103/physrevlett.118.242002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/07/2017] [Indexed: 06/07/2023]
Abstract
We report the first beam-target double-polarization asymmetries in the γ+n(p)→π^{-}+p(p) reaction spanning the nucleon resonance region from invariant mass W=1500 to 2300 MeV. Circularly polarized photons and longitudinally polarized deuterons in solid hydrogen deuteride (HD) have been used with the CEBAF Large Acceptance Spectrometer (CLAS) at Jefferson Lab. The exclusive final state has been extracted using three very different analyses that show excellent agreement, and these have been used to deduce the E polarization observable for an effective neutron target. These results have been incorporated into new partial wave analyses and have led to significant revisions for several γnN^{*} resonance photocouplings.
Collapse
|
235
|
Szczepny A, Rogers S, Jayasekara WSN, Park K, McCloy RA, Cochrane CR, Ganju V, Cooper WA, Sage J, Peacock CD, Cain JE, Burgess A, Watkins DN. The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer. Oncogene 2017; 36:5544-5550. [PMID: 28581526 PMCID: PMC5623150 DOI: 10.1038/onc.2017.173] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2016] [Revised: 04/27/2017] [Accepted: 04/27/2017] [Indexed: 02/07/2023]
Abstract
Hedgehog (Hh) signaling regulates cell fate and self-renewal in development and cancer. Canonical Hh signaling is mediated by Hh ligand binding to the receptor Patched (Ptch), which in turn activates Gli-mediated transcription through Smoothened (Smo), the molecular target of the Hh pathway inhibitors used as cancer therapeutics. Small cell lung cancer (SCLC) is a common, aggressive malignancy with universally poor prognosis. Although preclinical studies have shown that Hh inhibitors block the self-renewal capacity of SCLC cells, the lack of activating pathway mutations have cast doubt over the significance of these observations. In particular, the existence of autocrine, ligand-dependent Hh signaling in SCLC has been disputed. In a conditional Tp53;Rb1 mutant mouse model of SCLC, we now demonstrate a requirement for the Hh ligand Sonic Hedgehog (Shh) for the progression of SCLC. Conversely, we show that conditional Shh overexpression activates canonical Hh signaling in SCLC cells, and markedly accelerates tumor progression. When compared to mouse SCLC tumors expressing an activating, ligand-independent Smo mutant, tumors overexpressing Shh exhibited marked chromosomal instability and Smoothened-independent upregulation of Cyclin B1, a putative non-canonical arm of the Hh pathway. In turn, we show that overexpression of Cyclin B1 induces chromosomal instability in mouse embryonic fibroblasts lacking both Tp53 and Rb1. These results provide strong support for an autocrine, ligand-dependent model of Hh signaling in SCLC pathogenesis, and reveal a novel role for non-canonical Hh signaling through the induction of chromosomal instability.
Collapse
|
236
|
Koh Y, Byun J, Kim Y, Lee D, Park K, Yoon S, Bea G, Kim D. REDEFINING THE ROLE OF ETOPOSIDE IN PERIPHERAL T-CELL LYMPHOMA TREATMENT. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
237
|
Abstract
Under hypotonic conditions, the regulatory volume decrease (RVD) is essential to maintain physiological homeostasis and functions in diverse biological systems. Intracellular Ca2+ has been reported as an important mediator of this response, but the underlying Ca2+ mechanism responsible for RVD is still controversial. Here we investigate the role of Ca2+ in the RVD response using live-cell imaging, microspectrofluorimetry, and a patch-clamp technique. A typical RVD was observed in submandibular gland acinar cells after swelling in a hypotonic solution, whereas intracellular Ca2+ chelation completely inhibited the RVD response. The incidence and magnitude of the Ca2+ transient were proportional to the degree of hypotonicity of the extracellular medium, and there was a close relationship between intracellular Ca2+ concentration and the volumetric changes of the cells. Notably, this response was mediated by Ca2+-induced Ca2+ release, which is triggered by Ca2+ influx via stretch-activated TRPM7 channels. Furthermore, we detected the generation of Cl- currents in the swelling acinar cells upon hypotonic stress, and the current profile matched that of the Ca2+-activated Cl- currents. A specific inhibitor of Cl- currents also inhibited the RVD response. In conclusion, an intracellular Ca2+ increase in response to osmotically induced cell swelling plays a critical role in RVD in salivary gland acinar cells.
Collapse
|
238
|
Jung J, Hur Y, Lim C, Shin K, Kim H, Chung H, Park K. 596 ICP-5249 attenuates psoriatic inflammation through autophagy. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
239
|
Na J, Choi J, Huh C, Shin J, Park K. 656 Changes of lesional and non-lesional skin microbiome in the treatment course of atopic dermatitis. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
240
|
Park H, Shin K, Kim J, Ahn S, Kim S, Kim Y, Park W, Kim Y, Shin S, Kim J, Lee S, Kim K, Park K, Jeong B. PV-0235: Is there a subset who benefits from PMRT in node-negative breast cancer patients? Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30678-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
241
|
Kim K, Cho Y, Shin K, Lee Y, Yokota M, Chae S, Park K, Uchida Y. 414 Both sphingosine kinase 1 and 2 coordinately regulate cathelicidin antimicrobial peptide production during keratinocyte differentiation. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
242
|
Yoo G, Oh D, Noh J, Ahn Y, Baek C, Son Y, Jeong H, Sun J, Ahn M, Park K. EP-1070: Concurrent chemoradiation versus upfront surgery for clinical T3-4 hypopharynx and larynx cancer. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31506-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
243
|
Gupta S, Iv V, Klaric K, Park K. Impact of Helmet Usage on Clinical Presentation and Outcome of Traumatic
Brain Injury in Motorcycle Operators in Cambodia. Ann Glob Health 2017. [DOI: 10.1016/j.aogh.2017.03.190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
244
|
Garassino M, Cho BC, Gray J, Mazières J, Park K, Soo R, Dennis P, Huang Y, Wadsworth C, Rizvi N. Durvalumab in ≥ 3rd-line EGFR mutant/ALK+, locally advanced or metastatic NSCLC: Results from the phase 2 ATLANTIC study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.002] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
245
|
Cho E, Kang J, Han JY, Lee J, Kim DW, Kim SW, Min Y, Lee K, Kim JH, Park K. Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
246
|
Yang JH, Paz-Ares L, Tan EH, O'Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Fan J, Park K. Afatinib vs gefitinib for treatment-naïve patients with EGFRm+ NSCLC (LUX-Lung 7): Analysis of time to treatment failure and impact of afatinib dose adjustment. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
247
|
Schuler M, Paz-Ares L, Sequist L, Wu YL, Geater S, Märten A, Fan J, Park K, Yang JH. First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders (LTRs) in the LUX-Lung (LL) 3, 6 and 7 trials. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
248
|
Hofmeyr R, McGuire J, Douglas-Jones P, Proxenos M, Park K, Lubbe D. Multilevel dilatation of tracheal and bronchial stenosis using a non-occlusive tracheal dilatation balloon in a patient with sclerosing airway disease. J Cardiothorac Vasc Anesth 2017. [DOI: 10.1053/j.jvca.2017.02.066] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
249
|
Hofmeyr R, McGuire J, Marwick P, Park K, Proxenos M, Lehmann M, Weich H. Continuous ventilation during tracheal dilatation using a novel, non-occlusive tracheal balloon dilator in an ovine model. J Cardiothorac Vasc Anesth 2017. [DOI: 10.1053/j.jvca.2017.02.173] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
250
|
Artal-Cortes A, Mazieres J, Fehrenbacher L, Rittmeyer A, Spira A, Park K, Lewanski C, Liu S, Ballinger M, Vansteenkiste J. Evaluation of non-classical response by immune-modified RECIST and efficacy of atezolizumab beyond disease progression in advanced NSCLC: Results from the randomized Phase II study POPLAR. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|